ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for monitor Customisable watchlists with full streaming quotes from leading exchanges, such as LSE, NASDAQ, NYSE, AMEX, Bovespa, BIT and more.

AGL Angle Plc

14.50
0.50 (3.57%)
26 Apr 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Angle Plc LSE:AGL London Ordinary Share GB0034330679 ORD 10P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.50 3.57% 14.50 14.00 15.00 15.00 14.00 14.00 1,310,616 10:04:36
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
Business Services, Nec 1.04M -21.69M -0.0832 -1.74 37.78M
Angle Plc is listed in the Business Services sector of the London Stock Exchange with ticker AGL. The last closing price for Angle was 14p. Over the last year, Angle shares have traded in a share price range of 9.125p to 37.50p.

Angle currently has 260,580,547 shares in issue. The market capitalisation of Angle is £37.78 million. Angle has a price to earnings ratio (PE ratio) of -1.74.

Angle Share Discussion Threads

Showing 32001 to 32023 of 32675 messages
Chat Pages: Latest  1283  1282  1281  1280  1279  1278  1277  1276  1275  1274  1273  1272  Older
DateSubjectAuthorDiscuss
08/3/2024
08:15
Twogood2die on LSEBones699Paul Planet Earth Same person. CLOWN
zeus19
08/3/2024
08:14
Yup do your own research..£130m cash burnt through and down to just 6 months cash left in the kitty...absolutely zero commercial deals in the pipeline and the cash runway into Q2 2025 looks absurdly unattainable meaning an inevitable cash raise and probably sub 12p unless Newland can pull the wool over investors eyes!
bones699
08/3/2024
08:08
There's only one thing sad round here...and it ends in 699....should have done it ages ago....filtered...
sawney
08/3/2024
08:01
Feeling very positive this morning!
Everything pointing to good preparation for commercialization phase now with new specialist recruitment underway.
Company has already stated cash runway well into 2025
News on further data likely
Not sure why some people have something against this company?? Do you own research

spa362
08/3/2024
07:38
Oh dear how sad from the LSE BB.

TwoGood2Die

Cash Running Out!

Today 07:35

"June 2023 they had £20m cash remaining by December they had no doubt burnt through £9m and despite the US lab closure are probably still burning through well over £1m a month meaning only £7m cash remaining enough to last just 6 months till Q3 this year....yet still no signs of that elusive £6m Newland promised!....maybe AGL needs to consider other alternative 'strategic initiatives' to a cash raise as referenced at January's Investor Meet, whatever that was supposed to mean, no details provided by Newland, that figures!"

bones699
07/3/2024
20:32
What a daft analogy...keep falling off your chair.You sit on it long enough now as you got sacked...rumour has it.Dr James M ReubenWe look forward to the further development of CTC based assays that may bring enormous benefits to patients with MBC as well as other cancers in the future."It's the first mover advantage that is so valuable here
muffster
07/3/2024
17:03
Unfortunately that's the reality here Newland sold an empty dream to investors.

If you recall at the Investor Meet in London back in January when asked about FDA approval...Newland replied by saying that Parsortix could be used for testing other cancers than breast cancer so long as the laboratory concerned seeks accreditation from the FDA to do so.

...at which point I nearly fell out of my chair..

..Its bit like a car salesman saying to a would be buyer the new car can be used for going up to speeds of 10 mph in first and second gears only but if you want it go much faster you need to apply to the NCAP 'New Car Assessment Program' to ensure the vehicle meets all the stringent safety points and regulations!

Hence why Parsortix has had zero commercial deals signed to date.

bones699
07/3/2024
15:23
FFS,they better start generating some significant revenue streams!
Solaris must be properly pi..ed off!
Abbot presumably nowhere to be seen,along with Philips and the other machinery
Makers.
Are we going to become solely a consumables supplier?
Somebody please take us out!

fhmktg
07/3/2024
13:14
Prostate and Ovarian kicked into long grass and that delay as well as with KRAS and EGFR obscured by big fanfare and new marquee project on BiDetect

The delay either deliberate refocus or I think more likely they suffered delays with third party equipment and have now had to bring in house. The samples for these two LDTs were in storage last we heard to be run later in 2024

bagpuss67
07/3/2024
12:53
Yup let's start recruiting now when that should have been done last year..It takes a very long time to establish sales networks and contacts and time is marching on and no commercial deals have been established while cash is running out!

The other way to look at things why aren't the two largest laboratory chains in the USA Quest Diagnostics and LabCorp not interested?

bones699
07/3/2024
10:59
Wouldn't that depend on whether the sales people actually prove to be any good?

I hope we can take some comfort from the fact they appear to believe they actually have something to sell.

arthur_lame_stocks
07/3/2024
10:55
Re the two job offers, it sounds to me as though they aren’t generating enough interest from anywhere,so now they want a telephone sales person to generate leads for a senior sales person to go and try and sell the products, doesn’t bode well.
bobbie121
07/3/2024
07:12
Another positive indicator that to date AGL haven't generated any commercial deals and are very unlikely to do so in future.

Q2 about to start and absolutely no signs of Newlands fabbled £6m additional revenues..

"Hello Mr Large USA Lab Chain, I have got a new testing machine called Parsortix its great at testing for just one cancer that's like 4% of all cancers...but don't you worry you can test it for all known cancers as long as you are accredited"...Newland

Two seconds later the door is slammed firmly in his face!

bones699
06/3/2024
14:55
I also note NEW positions at AGL (posted today) - another positive indicator:-SENIOR SALES MANAGER - BIOPHARMA SERVICES:• The role of the Senior Biopharma Service Sales Manager is to drive revenue growth for ANGLE's biopharma services, assay development programs, and strategic alignments within the life science industry. This is done by proactively approaching potential customers within the life science industry (pharma, academic centres, esoteric laboratories, etc.) where ANGLE's Parsortix and liquid biopsy services can be of great value in support of their oncology drug development and companion diagnostic test development process. This role will work directly with the Chief Commercial Officer, R&D, clinical team, product sales, product managers and marketing.-INSIDE SALES REP:• Works in tandem our sales team to provide customers with ANGLE liquid biopsy solutions. Main responsibilities will be to generate high quality sales leads including pharmaceutical, biotechnology and esoteric CLIA laboratories, that fall directly within ANGLE's target market segment.?The job holder will help drive global sales and is accountable to meet established sales targets. This position interfaces with multiple departments across the organisation, to represent customer and sales force interests.-Https://angleplc.com/about-us/careers/
5oletrader
06/3/2024
12:26
Nice to see a bit of buying News cant be far off
rb1947
06/3/2024
10:25
Jelenko - it doesn't think period. It's not about content and more about volume. That's why it's easy to ignore.
boris cobaka
06/3/2024
09:23
Bones

Exactly so - 'FDA are there for a reason to prevent misdiagnosis and miss use (sic) of the wrong drugs' etc. etc.

You have simply highlighted what a huge achievement it is for this small UK company to secure the world's first and only FDA approval for CTC capture for subsequent analysis. It validates the system and gives Angle a huge competitive advantage in a rapidly emerging market.

bermudashorts
06/3/2024
09:09
FDA not required if the company using it does so in a lab that has certain accreditation and you can be sure that the major pharma's have this so its no longer an issue. Having ben awarded approval for one cancer situation gives validation to the Parsotix system full stop.Too much typing not enough thinking..!!!
jelenko
06/3/2024
08:39
FDA approval is there for a reason to prevent misdiagnosis and miss use of the wrong drugs and treatments which could be fatal..This is an investment case without full FDA approval Parsortix has no future, period!
bones699
06/3/2024
08:35
'Shame aint it that Parsortix is only FDA approved for testing 1 of 24 major cancer groups!..🤒😷🤢 9326;🤧'


bones699...If your wife or daughter was dying of cancer, wouldn't you be interested in knowing which one it is or is not?

htrocka2
06/3/2024
08:08
Shame aint it that Parsortix is only FDA approved for testing 1 of 24 major cancer groups!..🤒😷🤢 9326;🤧
bones699
06/3/2024
08:06
Time for a top-up methinks.

Ready for the next burst to 20p.

Amazing value with full patents and clearance in the US!

Big Pharma looking.....

philjeans
06/3/2024
07:49
Good spot Bermudashorts.

Meanwhile the undernoted article underlines (what we already know) re the importance of Angles Parsortix technology & particularly in light of the recent molecular results.

H ttps://www.bristolpost.co.uk/news/health/life-extending-cancer-treatment-blocked-9143280

Ps.Delete space after H for link

gooosed
Chat Pages: Latest  1283  1282  1281  1280  1279  1278  1277  1276  1275  1274  1273  1272  Older

Your Recent History

Delayed Upgrade Clock